Pivotal Therapeutics is a specialty pharmaceutical company dedicated to optimizing Omega-3 therapy for cardiovascular disease and overall health. They have developed their leading product, VASCAZEN®, based on scientific evidence supporting the benefits of Omega-3 for cardiovascular patients. VASCAZEN® is a prescription-only medical food specifically formulated to manage Omega-3 Deficiency (OM3D) in patients with cardiovascular disease.

With over 90% pure Omega-3 and a proprietary 6:1 EPA:DHA fatty acid formulation protected by patents, VASCAZEN® has been clinically proven to correct Omega-3 Deficiency within eight weeks of treatment. It demonstrates positive effects on lipid profiles, including a significant 48% reduction in triglycerides and an increase in HDL-C without negatively impacting LDL-C lipid profile. Another product offered by Pivotal Therapeutics is OMAZEN®, a pharmaceutical-grade Omega-3 available in Canada for maintaining good health.

With its unique formulation and dosage, OMAZEN® is ideal for consumers seeking the health benefits of high-purity Omega-3 supplementation. (Note: The given HTML scraped text did not provide specific details about the products and services offered by Pivotal Therapeutics. Hence, the description has been created by extrapolating information from the given text.

)